A stress-induced cellular aging model with postnatal neural stem cells by Dong, C.-M. et al.
OPEN
A stress-induced cellular aging model with postnatal
neural stem cells
C-M Dong1,2,3,8, X-L Wang1,8, G-M Wang1,8, W-J Zhang4, L Zhu1, S Gao1, D-J Yang1, Y Qin1, Q-J Liang2,5, Y-L Chen6, H-T Deng6,
K Ning1,7, A-B Liang*,4, Z-L Gao*,2,5 and J Xu*,1
Aging refers to the physical and functional decline of the tissues over time that often leads to age-related degenerative diseases.
Accumulating evidence implicates that the senescence of neural stem cells (NSCs) is of paramount importance to the aging of
central neural system (CNS). However, exploration of the underlying molecular mechanisms has been hindered by the lack of
proper aging models to allow the mechanistic examination within a reasonable time window. In the present study, we have
utilized a hydroxyurea (HU) treatment protocol and effectively induced postnatal subventricle NSCs to undergo cellular
senescence as determined by augmented senescence-associated-b-galactosidase (SA-b-gal) staining, decreased proliferation
and differentiation capacity, increased G0/G1 cell cycle arrest, elevated reactive oxygen species (ROS) level and diminished
apoptosis. These phenotypic changes were accompanied by a significant increase in p16, p21 and p53 expression, as well as a
decreased expression of key proteins in various DNA repair pathways such as xrcc2, xrcc3 and ku70. Further proteomic analysis
suggests that multiple pathways are involved in the HU-induced NSC senescence, including genes related to DNA damage and
repair, mitochondrial dysfunction and the increase of ROS level. Intriguingly, compensatory mechanisms may have also been
initiated to interfere with apoptotic signaling pathways and to minimize the cell death by downregulating Bcl2-associated
X protein (BAX) expression. Taken together, we have successfully established a cellular model that will be of broad utilities to the
molecular exploration of NSC senescence and aging.
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Aging is characterized by progressive declines in the
physiology and functionality of adult tissues and can manifest
nine common hallmarks: genomic instability, telomere attri-
tion, epigenetic alterations, loss of proteostasis, deregulated
nutrient sensing, mitochondrial dysfunction, cellular sene-
scence, stem cell exhaustion and altered intercellular com-
munication.1 At cellular levels, these age-dependent declines
can arise from the accumulation of damage and erosion to
cellular macromolecules including proteins, RNA and DNA,
usually a result of cellular stress and environmental insults.2
Of these, DNA damage accrual and insufficient DNA repair
often accompanied by oxidative stress and mitochondrial
dysfunction is a principal factor contributing to cell sene-
scence and aging.3 Conversely, DNA repair pathways delay
cell senescence and aging by maintaining genomic integrity.4
Perhaps the fundamental importance of DNA damage control
in aging is best illustrated by the fact that human monogenic
progeroid syndromes are caused almost exclusively by
mutations in DNA repair genes whose deficiency also result
in premature aging in mouse models.5 DNA damage
accumulation may also be a major force to drive resident
stem cell aging and eventual exhaustion. Genetic lesions with
DNA repair pathway components inmousemodels profoundly
impact resident stem cell integrity through various mechan-
isms.5 For example, DNA damage accumulates in aged
hematopoietic stem cells (HSCs) and defects in DNA damage
repair pathway cause HSC deficiency and hematopoietic
abnormalities.6,7 Besides, DNA lesions in stem cells could
propagate both to daughter stem cells and to downstream
lineages. Therefore, the capability of stem cells to cope with
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DNA damage will have profound impact on the genomic
integrity of stem cells and their progenies.
Adult neural stem cells (NSCs) are essential for brain
homeostasis but suffer from proliferative declines and cellular
senescence with age.8 The decreased proliferation,9,10
increased G0/G1 cell cycle arrest and reduced neuronal
neurogenesis11 gradually result in the loss of repair and
regeneration capacity, contributing to neural aging and
disorders such as olfactory dysfunction,12 spatial memory
deficits13 and neurodegenerative diseases.14,15 Various
intrinsic factors can modulate this functional decline and thus
brain aging.16–19 For example, the age-dependent increase of
the senescence regulators (e.g., p16) contributes to the
diminishing of aged NSC pool.20 Adult neurogenesis is also
sensitive to environmental stress (e.g., DNA damage).
A single dose of 10Gy radiation exposure led to long-lasting
cognitive impairment21 and deficiency in DNA double-strand
break (DSB) repair could result in precocious neuro-
genesis and ultimately decreased neuronal production.22
Despite these progresses, molecular characterizations of
the responses of adult NSCs to DNA damage and their
functional importance are largely absent.23 Equally lacking is
whether and how adult NSCs have developed compensatory
mechanisms to combat the devastating consequences
caused by excessive DNA damage and aging.
The aging of NSCs is a difficult subject to study, on one
hand, because of the sparsity and no easy accessibility of
in vivo experimental materials and, on the other hand,
because of the lack of proper models to manipulate the key
genes and examine the molecular mechanisms within
relatively short periods of time. Thus, establishing in vitro
models of NSC aging becomes vital to elucidate NSC aging
mechanisms. Hydroxyurea (HU) initially used as an anti-
neoplastic drug24 represses the ribonucleotide reductase and
decreases the production of deoxyribonucleotides. Thus, it
can incur DSBs near replication forks and function as a DNA
replication inhibitor for both nuclear and mitochondrial DNA,
causing cellular and mitochondrial stress and dysfunction.25
It can induce senescence-like changes in various cell lines
but in NSCs its effect remains undetermined.26
In the current study, utilizing HU treatment we have
optimized and carefully characterized a cellular NSC aging
model that could recapture many of the aging attributes.
Further proteomics analysis unraveled molecular networks
related to diverse aging hallmarks, suggesting the broad
utilities of our cellular model for mechanistic dissection of NSC
and neural aging.
Results
Establishment and characterization of primary NSC
culture. NSCs from the subventricular zone (SVZ) of
postnatal day 7 (P7) mice were cultured in the presence of
epidermal growth factor (EGF) and basic fibroblast
growth factor (bFGF) and formed neurospheres in vitro
(Supplementary Figure S1A). During subculturing, the NSC
culture maintained their stem cell characteristics and stained
positively for Nestin and SOX2 (Supplementary Figure S1B).
It can also undergo differentiation toward neurons, astrocytes
and oligodendrocytes (Supplementary Figures S2 and S3).
Persistent DNA damage induced by HU treatment. To
determine the optimal dosing of HU to induce DSBs and cell
senescence, NSCs were treated for 1 and 12 h at three
different doses of 0.5, 8 and 20mM. The treatment with
20mM HU caused cell death as manifested by DNA
fragmentation and apoptotic bodies (Figure 1a), but low
and medium dosing of HU did not obviously change the NSC
culture. We then examined the extent of DSBs by quantifying
gH2AX foci that form at the sites of DNA damage. Untreated
NSCs displayed a basal level of gH2AX foci. The treatment of
0.5mM HU for 1 or 12 h or of 8mM HU for 1 h induced an
immediate increase in gH2AX foci number that declined
rapidly and returned to the baseline at 36 h post treatment.
The treatment of 8mM HU for 12 h triggered rapid increase in
gH2AX foci number but that failed to go down even at 36 h
post treatment (Figures 1b and c).
Establishment of a NSC aging model using mild DNA
damage treatment. Our results demonstrated that the low
dosing of HU only induced transient DSBs, whereas the high
dosing of HU was incompatible with NSC survival. Therefore,
for further experimentations, we opted to use mild dosing
of HU (8mM HU, 12 h) that produced persistent DSBs
(Figure 1c).
To verify whether we can establish a cellular NSC aging
model with 8mM HU treatment, a series of characterizations
were performed. First, we carried out neurosphere
formation assays and our results showed that the ratio of
neurosphere formation was markedly reduced in the
HU-treated group (Figures 2a and b), suggesting the
self-renewal capacity of NSCs is significantly impaired by
the treatment. Upon exposure to 1% FBS, the majority
of the cells in both groups spontaneously differentiated
into GFAPþ cells with typical astrocyte morphology
(Figures 2c and d). A small fraction of the cells
became Tuj1þ neurons with multipolarized processes.
The proportion of neurons in HU-treated cells was
significantly decreased (Figures 2c and d), indicating that
the neuronal differentiation ability of NSCs was significantly
compromised by the treatment.
To test whether this mild DNA damage treatment causes
cell senescence in NSCs, we stained the NSCs with the
senescence-associated-b-galactosidase (SA-b-gal), an
established senescence marker. HU treatment induced
robust b-galactosidase expression (Figure 3a). The percen-
tage of SA-b-gal positive NSCs increased from 8.39% in the
control group to 26.63% in the HU-treated one (Figure 3b).
Cell senescence is usually accompanied by increased
intracellular reactive oxygen species (ROS) level. Consistent
with that, the HU-treated NSCs had higher ROS level than the
control cells (Figures 3c and d).
DNA damage usually induces cell cycle arrest and
apoptosis. To assay that, we performed fluorescence-
activated cell sorting (FACS) experiment. As determined
by propidium iodide (PI) staining (Figure 3e), HU treatment
induced a significant increase in G0/G1 phases and a
significant decrease in G2/M populations (Figures 3f and g).
Intriguingly, mild HU treatment reduced the level of
apoptosis in NSCs compared with the control treatment
(Figure 3h).
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Aging-related genes and pathways altered in the model.
Mild HU treatment not only diminished NSC proliferative
capability and neuronal differentiation potential but also
induced senescence-related phenotypes, implying successful
establishment of a cellular aging model. However, it remained
to be determined whether our model can recapitulate
molecular mechanisms related to aging. Thus, we next
sought to validate the model through analyzing known
aging-related genes and pathways.
p53/p21 pathway is crucial in cellular response to DNA
damage27 and p16 is a cyclin-dependent kinase inhibitor. Both
are major pathways controlling cell cycle arrest and cell
senescence.28 Consistent with our expectation, mild HU
treatment led to a significant increase in the expression of
p16, p21 and p53 as unraveled by QRT-PCR (Figure 3i) and
western blot (Figure 3j) analyses.
One major effect of mild HU treatment is the persistent
DSBs that might result from compromised DNA damage
repair. Therefore, we examined the expression of somemajor
genes for DNA damage repair including key components of
the homologous recombination (HR) repair pathway (e.g.,
xrcc2 and xrcc3) and the nonhomologous end joining (NHEJ)
repair pathway (e.g., ku70, xrcc4 and ligase4). HU treatment
decreased the expression of both the HR and NHEJ pathway
genes (Figures 3k–n), which could be underlying HU-induced
persistent DNA damage, leading to NSC senescence.
Taken together, our HU treatment system effectively
recaptured broad aspects of aging at both phenotypical and
molecular levels and shall constitute a valid cellular aging
model for further exploration.
Proteomic analysis unraveling major molecular
pathways related to NSC aging. The establishment of
the cellular aging model enables us to use genome-wide
approach and systematically explore the mechanisms that
count for the aging-related declines in an unbiased manner.
To demonstrate such utilities, we performed quantitative
proteomic analysis and sought to identify key proteins and
pathways modulating the aging process. Our analysis
produced 1209 distinct proteins. With a 2.0-fold cutoff, 48
proteins were found to be upregulated and 19 proteins were
downregulated (Figure 4 and Supplementary Table S2).
Functionally, these proteins are mainly associated with
cellular aging, cell cycle arrest, mitochondrial integrity, ROS
and stress response, DNA damage response and cell death
(Figures 4 and 5).
We then performed bioinformatic analyses on the differen-
tially expressed proteins using the DAVID Bioinformatics
Figure 1 Persistent DNA damage induced by HU treatment. (a) NSCs were treated with 0.5, 8 and 20 mM HU for 1 or 12 h respectively and stained with Nestin, SOX2 and
DAPI post treatment. The white arrows point to apoptotic bodies. Scale bar: 20 mm. (b) Formation of DNA double-strand breaks in NSCs post HU treatment. NSCs were
treated with 0.5 and 8 mM HU for 1 or 12 h and allowed to recover until 36 h post treatment. Cells were fixed and stained for gH2AX foci (red) at the indicated time points post
HU treatment. Scale bar: 5 mm. (c) Graphical depiction of the number of gH2AX foci in NSCs treated with 0.5 or 8 mM HU over 36 h. Data are expressed as mean±S.E. from
three independent experiments. *Po0.05, ***Po0.001, two-way ANOVA with Fisher’s post hoc test (see Supplementary Table S1)
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Resource 6.7 (http://david.abcc.ncifcrf.gov/) and Ingenuity
Pathway Analysis (IPA; Ingenuity Systems: http://www.
ingenuity.com). The majority of the differentially expressed
proteins are located in the lysosome (37%), the nucleus
(26%) and the mitochondrion (10%) (Figure 5a). These
proteins predominantly fall in the canonical pathways related
to mitochondrial dysfunction and energy metabolism
(Figure 5b). The top five enriched biological processes
(Po0.001) are nucleic acid metabolism, small molecule
biochemistry, energy production, lipid metabolism and
post-translational modification (Figure 5c). For physiological
system development and function, behavior, hair and skin
development and nervous system development function were
among the top (Figure 5d). Importantly, upon HU treatment,
many of the proteins underwent expression changes in a
highly correlated manner and readily formed some canonical
pathways associated with certain aging hallmarks such
as mitochondrial dysfunction (e.g., superoxide dismutase 2
(SOD2), cytochrome c oxidase subunit II (COX2), NADH
dehydrogenase 1b subcomplex 9 (NDUFB9), NDUFB10,
NADH dehydrogenase 1a subcomplex 2 (NDUFA2),
NDUFAF4 and ATP synthase-Hþ transporting-mitochondrial
F1 complex-a subunit 1 (ATP5A1))29–33 as well as deregu-
lated nutrient sensing and metabolisms (tricarboxylic acid
cycle cycle (TCA), pyruvate fermentation lactate and b-fatty
acid oxidation I) (Figure 5b).
To extrapolate major cellular functional networks altered in
HU-treated NSCs, we performed IPA pathway analysis.
Again, several networks relevant to aging hallmarks were
readily grouped together. The most significant network
contains 26 proteins relating to DNA replication, recombina-
tion and repair, ROS, energy production and nucleic acid
metabolism (Figure 6a). Importantly, the expression patterns
of these proteins are highly correlated with the cellular
phenotypes observed. For example, peroxiredoxin 1 (PRDX1)
and SOD2 was decreased in the HU-treated cells (Figure 6b),
consistent with the increased ROS and NSC senescence. We
then validated the proteomic data by RT-PCR and QRT-PCR.
As shown in Figures 6c and d, the relative expression level of
PRDX1 and SOD2 mRNA decreased by 30 and 70% in the
HU-treated cells, in perfect accord with the quantitative
proteomic results.
Figure 2 Proliferation and differentiation of HU-treated NSCs. (a) In vitro proliferative capacity of NSCs assayed by colony formation experiment. Representative images
of neurospheres from control (Con) and HU-treated (HU) cells. The number of neurospheres formed after 1 week was counted. D0 shows the plated NSCs after single-cell
dissociation at day 0. D7 shows the neurosphere formed after 7 days of culturing. Scale bar: 60 mm. (b) Statistics for the ratio of neurosphere formation after 7 days in vitro.
Mean±S.E. from three independent experiments. *Po0.05, Student’s t-test. (c) In vitro differentiation of neurospheres from control and HU-treated cells as determined by
the neuronal marker (Tuj1) and the astrocyte marker (GFAP). Cells showed a decreased proportion of neural progeny in the HU-treated group. Scale bar: 50mm. (d) Statistics
for the percentage of Tuj1þ and GFAPþ cells out of all cells formed from control and HU-treated cells. Ast, astrocyte; Neu, neuron. Mean±S.E. from three independent
experiments. *Po0.05, Student’s t-test
Figure 3 Phenotypic and molecular characterization of 8 mM HU-treated NSCs. (a) Images of SA-b-galþ NSCs with or without HU treatment. (b) Statistics of the
percentage of SA-b-galþ NSCs, mean±S.E. *Po0.05, Student’s t-test, Scale bar: 50mm. (c) ROS were detected using dihydroethidium (DHE) fluorescence. (d) ROS level
was normalized to that of control cells with statistics expressed as mean±S.E. *Po0.05, Student’s t-test. Scale bar: 60mm. (e–h) In NSCs, 8 mM HU treatment resulted in
irreversible cell cycle arrest and reduced apoptosis. Cell cycle analysis with (e) FACS analysis and (f–h) percentages of G0/G1, G2/M and apoptotic subpopulations are
presented as mean of percentage±S.E. (i and j) QRT-PCR analysis of p16, p21 and p53 expression normalized by GAPDH and western blotting analysis of p16 and p21
expression. (k–n) QRT-PCR analysis of HR (xrcc2 and brca1) and NHEJ (ku70, ligase4 and xrcc4) gene expression normalized by GAPDH (k and l), and western blotting
analysis of the related proteins (m and n). Values represent mean±S.E. of two independent samples conducted in triplicate. *Po0.05; **Po0.01, Student’s t-test
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Taken together, our proteomic exploration unraveled some
major aging-related pathways of both known and novel
players and showcased the potential to elucidate aging-
associatedmolecular mechanisms with the help of our cellular
model based on HU treatment of NSCs (Figure 6e).
Discussion
Aging and aging-related diseases represent a major social
and economic burden to the modern society. Numerous
efforts have been geared toward this direction, aiming at the
discovery of innovative therapeutic strategies to slow down or
reverse this process. However, aging by nature is a time-
dependent incremental progress and thus it is both time
consuming and challenging to perform mechanistic experi-
mentations, begging scalable aging models to enable
systematic and in-depth investigations within reasonable time
frames.
Among the different organs, central neural system (CNS)
presents particular challenging for the aging study, both for its
Figure 4 Heatmap analysis of differentially expressed proteins post HU treatment. The GO information was obtained from Gene Ontology Annotation database. The ratio
of protein expression between HU and control groups was presented as log2 values and represented by the lengths of the bar. The red and green bars stand respectively for
the upregulated and the downregulated. The subcellular location and biological function of each protein are allocated and indicated respectively by the red- and green-colored
spaces
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very complexity and its very importance. As such, despite
observations indicating the involvement of some major path-
ways in CNS and NSC aging, studies in these areas remain
scarce and essentially incoherent. Thus, it is of paramount
importance to establish NSC aging models and enable
systematic investigations in an unbiased manner.
In the present study, we treated postnatal NSCs with 8mM
HU for 12 h and successfully established an accelerated
cellular aging model. HU treatment not only induced
irreversible cell cycle arrest and senescence-like morphology,
but also caused elevated expression of senescence-related
genes and dysfunction of DNA damage repair machinery.
Consequently, the proliferative and neurogenic differentiative
capacity of NSCs was also impaired. Furthermore, chronic
DNA damage accumulation and decline of DNA repair
capacity were accompanied by increased intracellular ROS
level and reduced apoptosis (Figure 6e). These results
together demonstrate that premature senescence of cultured
Figure 5 Biological function analysis of the differentially expressed proteins post HU treatment. (a) The cellular component annotations of differentially expressed proteins
with GO analysis from DAVID database. (b) Top canonical pathways altered post HU treatment with mitochondrial dysfunction being the most significant one. (c) Molecular
and cellular function analysis of the differentially expressed proteins with nucleic acid metabolism, small-molecule biochemistry and energy production being the most
significant ones. (d) Physiological system development and function analysis of the differentially expressed proteins with the behavior, hair and skin development and nervous
system development being the most significant ones
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Figure 6 Candidate genes and pathways identified through the NSC cellular aging model associated with aging characteristics. (a) The key regulatory networks underlying
the HU-induced aging model. Proteomic data were imported into the IPA and interacting pathways were constructed with red representing an increase and green indicating a
decrease in protein expression. The color intensity represents the degree of expression change with the solid and dashed lines respectively indicating direct and indirect
interactions. (b) The mass spectra image for PRDX1 with LCMS/MS analysis. (c and d) Verification of PRDX1 and SOD2 expression by RT-PCR (c) and QRT-PCR (d) with
GAPDH as an internal control. The data are presented as mean±S.E. from three independent experiments. (e) The schematic diagram outlines the key players and pathways
that may mechanistically contribute to the phenotypes in our NSC aging model
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NSCs induced by HU treatment can recapitulate key elements
of aging in vivo and thus can serve as a useful aging model.
Our success of establishing NSC aging model enables
systematic investigations into the molecular mechanisms of
aging in an unbiased manner. As described above, DNA
damage and thus genomic instability is an inherent nature of
our aging model utilizing HU treatment. Naturally, we have
readily detected increases in DNA damage and changes in
DNA damage repair pathways (both HR and NHEJ) in HU-
treated NSCs (Figures 3k–n). Cell senescence was a major
phenotypic evidence for our aging model accompanied by an
upregulation of many key aging and senescence regulators
including p16, p21 and p53 (Figures 3i and j). The expression
of p16 increases in aged mouse and human tissues34 and the
increased expression of p16, p21 and p53 all led to decreased
NSC proliferation and neurogenesis.20 In response to
persistent DNA damage, the expression of p53, p21 and
p16 increased, ultimately contributing to halting cell prolifera-
tion to allow DNA repair to occur. We also observed a
decrease in PRDX1 expression in response to the HU
treatment (Figure 6c). Intriguingly, PRDX1-deficient fibro-
blasts manifested proliferation deficiency and were more
sensitive to oxidative DNA damage.35 Mechanistically loss of
PRDX1 accelerated mouse embryonic fibroblast (MEF)
senescence by increasing the phosphorylation of p53
(Ser19) upon persistent DNA damage.36 The role of PRDX1
in the neural system is completely unknown and it is
speculative that reduced PRDX1 expression is a causal factor
leading to NSC senescence.
Another hallmark of our NSC aging model is the increase in
intracellular ROS level (Figures 3c and d). We found a twofold
decrease in the expression of SOD2 in HU-treated NSCs
(Figures 6c and d). SOD2 is a main antioxidant enzyme that
scavenges ROS in the inner mitochondrial matrix and acts as
a first line of defense against mitochondrial oxidative stress.37
Mitochondrial oxidative damage resulted from SOD2 defi-
ciency promoted cellular senescence and aging phenotypes
in the skin.38 In concert, mice lacking PRDX1 manifested a
shortened lifespan owing to the severe hemolytic anemia
beginning at B9 months, characterized by an increase
in erythrocyte ROS, protein oxidation and hemoglobin
instability.35 Furthermore,NDUFB9andNDUFB10, components
of the mitochondrial complex I, were both downregulated in
HU-treated NSCs39 (Figure 6a) and their deficiency was
associated with mitochondrial dysfunction.40 ROS level was
thought to increase with age because of accumulating
mitochondrial damage in a self-perpetuating cycle.41
ROS-induced mitochondrial impairment further resulted in
increased ROS production that led to even more mitochon-
drial damage.2 As unraveled by our proteomic analysis, a
large number of proteins misregulated in our aging model
are related to mitochondrial dysfunction (Figure 5b), implying
the importance of mitochondrial homeostasis for aging and
the power of our cellular model.
The increased ROS can also exacerbate the DNA damage
repair and response.42 Besides the DNA damage response
pathways identified through RT-PCR analyses, our unbiased
proteomic analysis revealed that in HU-treated NSCs the
most enriched network (network 1) of 26 proteins is related to
DNA replication, recombination and repair, ROS, energy
production and nucleic acid metabolism (Figure 6a). Together
with recent reports,43,44 network 1 suggest that p38 MAPK
pathway may play an important role in NSC senescence.
Increased DNA damage and ROS are capable of activating
p38 MAPK pathway that in turn can upregulate senescence
genes such as p16.4
As is known, ROS are involved in many cellular metabolic
and signaling processes.45 Insights from our analysis of the
NSC aging model suggest the altered ROS pathways may
work in concert with changes in TCA cycle, pyruvate
fermentation lactate and b-fatty acid oxidation I (Figure 5b),
leading to deregulated nutrient sensing and metabolism, and
consequentially accelerated aging.
HU treatment induced irreversible cell cycle arrest and
impairment in the NSC proliferation and neurogenic potential,
in line with a stem cell senescence and exhaustion phenotype
(Figures 2 and 3). However, intriguingly, NSC apoptosis
decreased post HU treatment as unraveled by FACS analysis
(Figure 3e). This counterintuitive observation suggests an
adaptive response: NSCs adopt a compromised state to
prevent from being completely eliminated upon sublethal
insults such as (mild HU treatment-induced) persistent DNA
damage, largely mimicking the aging process. Indeed, similar
observations have been noted in other stem cell compart-
ments such as HSCs.46 As well, our proteomic analysis
revealed that the expression of BAX, a major pro-apoptotic
protein, was significantly downregulated in HU-treated NSCs
(Figure 6a), lending strong support to the notion of an adaptive
response.
Taken together, our data seem to support the following
model during HU-induced NSC aging. DNA damage induces
the expression of p53, p21 and p16, and the accompanying
repression of CDK2 (Figure 6e). Together, these changes
drive the NSCs to enter G1/S cell cycle arrest and help to
mitigate the devastating consequences induced by DNA
damage and allow time to repair. Contingent on the cellular
contexts, G1-arrested cells may enter apoptosis, senescence
(permanent quiescence) or reversible quiescence capable to
go back to cell cycle and proliferate. In our model, upon mild
dosing of HU, DNA damage caused cell cycle arrest and
overwhelmed DNA damage repair pathways whose down-
regulation further magnified the DNA damage effects. Con-
cordantly, DNA damage-associated stress (e.g., increased
ROS level) and the repression of anti-ROS/-cell senescence
genes (e.g., SOD2 and PRDX1) precipitated the arrested
NSCs to senescence, during which the adaptive down-
regulation of BAX contributed to the decreased apoptosis.
As afore-discussed, our current study demonstrates broad
utilities of the HU-induced NSC aging model to mechan-
istically dissect the diverse aspects of aging from genomic
instability, deregulated nutrient sensing and mitochondrial
dysfunction to cellular senescence and stem cell exhaustion.
Although this aging model has helped to reveal some major
networks underlying NSC aging, many questions remain,
such as given an aging insult, how organisms/cells make their
decisions to die or to compromise and adapt, how the status
and context of NSCs (e.g., quiescence and the age of the
cells) may influence the outcome of aging insults, how the
different aging insults are being sensed and the different
pathways being triggered, whether there are NSC-specific
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aging pathways and what they are, and whether and
how aged NSCs can be rejuvenated. Apparently, as an
in vitro system, this model is unlikely to faithfully recapture
every aspect of aging such as altered intercellular commu-
nication. As well, we are yet to test whether this model will be
of any usage to mimic the telomere attrition, epigenetic
alterations and loss of proteostasis – the remaining hall-
marks of aging. Nor have we validated our model using
complementary approaches. Finally, the relevance of our
in vitro model with physiological aging needs to be
comprehensively justified and ultimately shall be subjected
to in vivo scrutinization.
In conclusion, we have developed a protocol and estab-
lished an aging model using postnatal NSCs that can largely
recapitulate the in vivo aging characteristics. Based on this
model, we have identified genes associated with persistent
DNA damage, cell senescence, G1/S arrest, increased ROS
and compromised proliferation and differentiation. These
findings have rendered it possible to explore NSC aging
mechanisms in detail. Importantly, the availability of this aging
model provides us the opportunity to systematically discover
the key aging-related genes and elucidate how they work
together to endow the aging phenotypes and may someday
lead to innovative strategies to fight against aging and the
associated disorders.
Materials and Methods
Neurosphere culture. Primary NSC culture was derived from postnatal day
7 mice. The SVZ was isolated and enzymatically dissociated in Hank’s balanced
saline solution buffer (HBSS) (Invitrogen, Grand Island, NY, USA) containing
1 mg/ml trypsin (Invitrogen) at 371C for 10 min followed by 5 min of centrifugation
at 350 g upon trypsin inhibition (Invitrogen). The isolated cells were washed with
HBSS and resuspended in DMEM/F12 medium (Invitrogen) with 2% B27
(Invitrogen), 20 ng/ml EGF (R&D Systems, Minneapolis, MN, USA), 20 ng/ml
bFGF (R&D Systems) and 2 mM glutamax (Invitrogen). Neurospheres formed over
3 days of incubation with 5% CO2 at 371C. Subculturing was done every 3–4 days.
Experiments were performed with cultured cells between passages 3 and 7 except
those otherwise indicated.
HU treatment. Cells were seeded at 1 105 cells per ml in 24-well plates
(Corning Incorporated, Corning, NY, USA), treated with HU (Sigma, St. Louis, MO,
USA) at a concentration of 0.5, 8 or 20 mM, and incubated at 371C until the
collection time points.
SA-b-gal assay. Cellular senescence was determined by SA-b-gal staining.47
Staining was performed using the Senescence Cells Histochemical Staining Kit
(Sigma) according to the manufacturer’s guidelines with DAPI as counterstaining.
Positive staining was evaluated after 12–16 h incubation at 371C in a CO2-free
atmosphere. The blue stained cells from 10 different fields were counted with
results presented as a percentage of positive cells.
Western blot analysis. Cultured NSCs were washed with ice-cold PBS and
lysed with 2 SDS lysis buffer. Protein concentrations were determined by the
BCA protein assay kit (Pierce, Rockford, IL, USA). Proteins were separated on 8%
SDS-polyacrylamide gels (Bio-Rad Laboratories, Inc., Hercules, CA, USA) and
transferred to a PVDF membrane (Millipore, Billerica, MA, USA). Membranes were
blocked in 5% non-fat milk powder in TBS-T (0.1% Tween-20 in TBS), and
incubated with primary antibodies overnight at 41C. After washing in TBS-T,
membranes were incubated with HRP-conjugated secondary antibodies (Invitro-
gen) for 1 h at room temperature with signals detected using ECL Super Signal
(Pierce). Quantifications were done using Image-Quant Software (Molecular
Dynamics, Sunnyvale, CA, USA). The primary antibodies used include rabbit anti-
p16 (Abcam, Cambridge, MA, USA), anti-p21 (Abcam), anti-ku70 (Abcam), anti-
Xrcc2 (Abclonal Technology, Wuhan, China), anti-Xrcc3 (Abclonal Technology),
anti-Xrcc4 (Abclonal Technology) and mouse anti-bactin (Sigma).
Protein pathway analysis. GO annotation of the identified proteins
was done using DAVID (V6.7: http://david.abcc.ncifcrf.gov/). Differentially
expressed proteins were analyzed using IPA (Ingenuity Systems: http://
www.ingenuity.com). The overrepresented biological functions, molecular
networks and canonical pathways were generated based on information in the
Ingenuity Pathways Knowledge Base.
Statistical analysis. Data were analyzed by Student’s t-test and one-way
analysis of variance (ANOVA) followed by post hoc multiple comparison tests.
Significance was accepted at Po0.05.
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